FDA.reportPublic FDA data

Kisqali 200 MG (63) / Femara 2.5 MG (28) Daily Dose Carton

RxCUI
1923058
RxNorm name
Kisqali 200 MG (63) / Femara 2.5 MG (28) Daily Dose Carton
Display name
Kisqali 200 MG (63) / Femara 2.5 MG (28) Daily Dose Carton
Full name
Kisqali 200 MG (63) / Femara 2.5 MG (28) Daily Dose Carton
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:14

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
KISQALI FEMARA CO-PACKLETROZOLE AND RIBOCICLIBNovartis Pharmaceuticals Corporationaa5e4446-19cd-4235-a382-5b48bf6c3b2f2026-07-01Warnings, Adverse reactionsExact identifier
rxcui: 1923058

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
aa5e4446-19cd-4235-a382-5b48bf6c3b2fKisqali 200 MG (63) / Femara 2.5 MG (28) Daily Dose CartonSY25These highlights do not include all the information needed to use KISQALI FEMARA CO-PACK safely and effectively. See full prescribing information for KISQALI FEMARA CO-PACK. KISQALI ® FEMARA ® CO-PACK (ribociclib tablets; letrozole tablets), co-packaged for oral use Initial U.S. Approval: 201720250916
aa5e4446-19cd-4235-a382-5b48bf6c3b2fKisqali 600 MG - Femara 2.5 MG Daily Dose CartonSY25These highlights do not include all the information needed to use KISQALI FEMARA CO-PACK safely and effectively. See full prescribing information for KISQALI FEMARA CO-PACK. KISQALI ® FEMARA ® CO-PACK (ribociclib tablets; letrozole tablets), co-packaged for oral use Initial U.S. Approval: 201720250916
aa5e4446-19cd-4235-a382-5b48bf6c3b2fKisqali 600 MG - Femara 2.5 MG Daily Dose CartonPSN25These highlights do not include all the information needed to use KISQALI FEMARA CO-PACK safely and effectively. See full prescribing information for KISQALI FEMARA CO-PACK. KISQALI ® FEMARA ® CO-PACK (ribociclib tablets; letrozole tablets), co-packaged for oral use Initial U.S. Approval: 201720250916
aa5e4446-19cd-4235-a382-5b48bf6c3b2f{28 (letrozole 2.5 MG Oral Tablet [Femara]) / 63 (ribociclib 200 MG Oral Tablet [Kisqali]) } Pack [Kisqali Femara Co-Pack 600]BPCK25These highlights do not include all the information needed to use KISQALI FEMARA CO-PACK safely and effectively. See full prescribing information for KISQALI FEMARA CO-PACK. KISQALI ® FEMARA ® CO-PACK (ribociclib tablets; letrozole tablets), co-packaged for oral use Initial U.S. Approval: 201720250916